Aucatzyl is a chimeric antigen receptor (CAR) T-cell therapy, a type of therapy that uses genetic modification to train the ...

Chronic lymphocytic leukemia (CLL) treatment options depend on your diagnosis. In earlier stages, “watchful waiting” may be recommended. More advanced CLL may require a combination of therapies.

TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer that changes blood cells. It usually develops in the bone marrow, ...

Most patients with chronic lymphocytic leukemia eventually relapse. A bispecific antibody drug may give them "another can to ...

New treatments and adverse events impacting patient quality of life were among the topics of interest in 2024.

Leukemia that is caused by this genetic change is fast-growing and associated with poor treatment outcomes, frequent relapses, and survival of less than a year. The new approval is a “major ...

Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials ...

and potential treatment options for AML. Acute myeloid leukemia (AML) is caused by mutations in genes in certain cells of your bone marrow. This is the inner part of your bones that produces blood ...